These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7116849)

  • 41. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M; Sartoretto JN
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral contraceptive and Platelet lipid biosynthesis in female rats: dose-response relationship.
    Ciavatti M; Davenas E; Michel G; Renaud S
    Lipids; 1982 Feb; 17(2):111-4. PubMed ID: 7087684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids.
    Wiik P; Nordby J; Paulsen JE
    Acta Obstet Gynecol Scand; 1993 Oct; 72(7):550-5. PubMed ID: 8213103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
    Derman RJ
    Postgrad Med; 1990 Sep; 88(4):119-22. PubMed ID: 2204902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives.
    Mileikowsky GN; Nadler JL; Huey F; Francis R; Roy S
    Am J Obstet Gynecol; 1988 Dec; 159(6):1547-52. PubMed ID: 3061301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation.
    Yu AF; Wu SX; Liu JL; Liu AR; Li JZ; Wu JH; Hu ZZ; Yin BY; Xu GX; Fotherby K
    Contraception; 1988 May; 37(5):517-28. PubMed ID: 2457468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma lipids in women using progestogen-only oral contraceptives.
    Briggs M; Briggs M
    Br J Obstet Gynaecol; 1983 Jun; 90(6):549-52. PubMed ID: 6407518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations.
    Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA
    Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
    Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB
    Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).
    Cahill M; Mistry R; Chapman C; Wood JK; Barnett DB
    Br J Clin Pharmacol; 1992 Jan; 33(1):11-5. PubMed ID: 1540480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels.
    Behall KM; Moser PB; Kelsay JL; Prather ES
    Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Worthington M; Proudler AJ; Felton C; Sidhu M; Stevenson JC
    Contraception; 1993 Sep; 48(3):217-27. PubMed ID: 8222652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.